[July 25, 2017] |
|
Colleen Goggins Joins QuintilesIMS Board of Directors
QuintilesIMS (NYSE:Q), a leading provider of information, technology
solutions and contract research services to the life sciences industry,
announced the appointment of Colleen Goggins to its board of directors,
effective today. A senior executive at Johnson & Johnson for more than
three decades, Goggins retired in 2011 after serving ten years on J&J's
Executive Committee and as the Worldwide Chairman of its Consumer Group.
Under her leadership, the J&J global personal and healthcare portfolio,
comprising many of the most recognized consumer brands and medicines in
the world, grew to more than $16 billion in annual revenue.
"We are delighted that Colleen has accepted to join our board," said Ari
Bousbib, QuintilesIMS chairman and CEO. "She brings broad life sciences
experience, a proven commitment toward improving public health and
demonstrated leadership in developing and commercializing an array of
therapies."
Goggins is a member of the supervisory board of Bayer AG and a member of
the board of directors of TD Bank Group. Goggins is also a member of the
University of Wisconsin Foundation and serves on the boards of directors
of the University of Wisconsin Center for Brand and Product Management,
the Child Health Institute of New Jersey, the Institute of International
Education, and New York City Meals-on-Wheels.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated to
helping its clients improve their clinical, scientific and commercial
results. Formed through the merger of Quintiles Transnational and IMS
Health, QuintilesIMS's approximately 50,000 employees conduct operations
in more than 100 countries. Companies seeking to improve real-world
patient outcomes through treatment innovations, care provision and
access can leverage QuintilesIMS's broad range of healthcare
information, technology and service solutions to drive new insights and
approaches. QuintilesIMS provides solutions that span clinical to
commercial, bringing customers a unique opportunity to realize the full
potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS protects
individual privacy while managing information to drive healthcare
forward. These insights and execution capabilities help biotech, medical
device and pharmaceutical companies, medical researchers, government
agencies, payers and other healthcare stakeholders in the development
and approval of new therapies, and to identify unmet treatment needs and
understand the safety, effectiveness and value of pharmaceutical
products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170725006620/en/
[ Back To Mobile World Congress's Homepage ]
|